On behalf of patients and families impacted by cholangiocarcinoma (bile duct cancer), the Cholangiocarcinoma Foundation congratulates AstraZeneca and its positive results from the TOPAZ-1 Phase III trial....

NewsDesk  @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19...

By NewsDesk  @infectiousdiseasenews Jamaica’s Director of Family Health Services, in the Ministry of Health & Wellness, Dr. Melody Ennis announced Thursday that there have been no deaths due...

By NewsDesk  @infectiousdiseasenews Following the initial reports of rare side effects after vaccination with the AstraZeneca vaccine (Vaxevria), a registry study was initiated quickly. The study includes...

By NewsDesk  @infectiousdiseasenews The  Finnish Institute for Health and Welfare (THL) will consider the inclusion of the Johnson & Johnson coronavirus vaccine in the Finnish vaccine programme...

By NewsDesk  @infectiousdiseasenews In a follow-up on Norway’s pause in the use of the AstraZeneca vaccine, the Norwegian Institute of Public Health recommended stopping further use of the AstraZeneca...

By NewsDesk  @bactiman63 The Philippines Department of Health (DOH) reported 401 new COVID-19 deaths Friday, a new daily record in fatalities on the archipelago since the beginning of the pandemic. In...

By NewsDesk  @bactiman63 A few weeks ago, the European Medicines Agency (EMA) reported that the COVID-19 Vaccine AstraZeneca was not associated with an increase in the overall risk of blood clots. Today,...

By NewsDesk  @infectiousdiseasenews The Canadian National Advisory Committee on Immunization (NACI) Monday recommended that the AstraZeneca COVID-19 vaccine should not be used in adults under 55 years...

By NewsDesk  @bactiman63 The Swedish Public Health Agency recommends that Astra Zeneca’s covid-19 vaccine be used again in Sweden to protect people aged 65 and older against the disease. For younger...